These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 2091472)

  • 21. Surgical stage, final grade, and survival of women with endometrial carcinoma whose preoperative endometrial biopsy shows well-differentiated tumors.
    Eltabbakh GH; Shamonki J; Mount SL
    Gynecol Oncol; 2005 Nov; 99(2):309-12. PubMed ID: 16005945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uterine malignant mixed mullerian tumors should not be included in studies of endometrial carcinoma.
    Vaidya AP; Horowitz NS; Oliva E; Halpern EF; Duska LR
    Gynecol Oncol; 2006 Nov; 103(2):684-7. PubMed ID: 16797683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prognostic factors in cancer of the endometrium and therapeutic indications].
    Fossat C; Mage P; Marée D; Avril A; Pigneux J; Richaud P
    J Gynecol Obstet Biol Reprod (Paris); 1984; 13(5):573-8. PubMed ID: 6491199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical observation of young, middle-aged and elderly women with endometrial carcinoma].
    Dai FR; Peng GQ; Zhang Y; Chen CX
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 30(6):690-3. PubMed ID: 16708811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extended surgical staging for uterine papillary serous carcinoma: survival outcome of locoregional (Stage I-III) disease.
    Bristow RE; Asrari F; Trimble EL; Montz FJ
    Gynecol Oncol; 2001 May; 81(2):279-86. PubMed ID: 11330963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Uterine sarcomas: clinical and histopathological aspects. Report on 15 cases].
    Leung F; Terzibachian JJ; Aouar Z; Govyadovskiy A; Lassabe C
    Gynecol Obstet Fertil; 2008 Jun; 36(6):628-35. PubMed ID: 18538624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.
    Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG
    Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prognostic analysis of 151 patients with maxillary sinus malignant neoplasms].
    Guo GF; Yang AK; Xie RH; Chen ZH; Wu QL; Ou SM; Liu WW; Xia LP; Chen MY; Zhang JX; Wu JH
    Ai Zheng; 2004 Nov; 23(11 Suppl):1546-50. PubMed ID: 15566677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prognostic value of histological variants of adenosquamous carcinoma of the corpus uteri].
    Smirnov OA
    Vopr Onkol; 1984; 30(3):32-7. PubMed ID: 6710946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The significance of residual tumor after preoperative pelvic irradiation for stage II endometrial carcinoma.
    Larson DM; Copeland LJ; Gallager HS; Wharton JT; Gershenson DM; Rutledge FN
    Obstet Gynecol; 1987 Dec; 70(6):916-9. PubMed ID: 3684130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endometrial carcinoma: stage I. A retrospective analysis of 262 patients.
    De Palo G; Kenda R; Andreola S; Luciani L; Musumeci R; Rilke F
    Obstet Gynecol; 1982 Aug; 60(2):225-31. PubMed ID: 7155485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-dose-rate brachytherapy as the primary treatment of medically inoperable stage I-II endometrial carcinoma.
    Nguyen C; Souhami L; Roman TN; Clark BG
    Gynecol Oncol; 1995 Dec; 59(3):370-5. PubMed ID: 8522257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uterine papillary serous carcinoma: evaluation of long-term survival in surgically staged patients.
    Grice J; Ek M; Greer B; Koh WJ; Muntz HG; Cain J; Tamimi H; Stelzer K; Figge D; Goff BA
    Gynecol Oncol; 1998 Apr; 69(1):69-73. PubMed ID: 9571001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical and pathological analysis on 106 cases with uterine sarcoma].
    Liao Q; Wang J; Han J
    Zhonghua Fu Chan Ke Za Zhi; 2001 Feb; 36(2):104-7. PubMed ID: 11783345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prognostic factors of stage III endometrial carcinoma].
    Li J; Kong WM
    Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(3):198-200. PubMed ID: 19537039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cancers of the corpus uteri on the Côte-d'Or 1982-1990. Incidence, clinical stage and survival].
    Chaplain G; Cuisenier J; Milan C; Smail M; Janoray P; Collin F; Déchelotte D; Michiels-Marzais D; Jahier J; Michiels R
    Bull Cancer; 1994 Aug; 81(8):691-7. PubMed ID: 7703560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy.
    Nelson G; Randall M; Sutton G; Moore D; Hurteau J; Look K
    Gynecol Oncol; 1999 Nov; 75(2):211-4. PubMed ID: 10525373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.
    Amant F; Cadron I; Fuso L; Berteloot P; de Jonge E; Jacomen G; Van Robaeys J; Neven P; Moerman P; Vergote I
    Gynecol Oncol; 2005 Aug; 98(2):274-80. PubMed ID: 15972232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Histomorphologic prognostic factors in stage I endometrial cancers].
    Köhler U; Bilek K; Rosenkranz M
    Zentralbl Gynakol; 1987; 109(20):1245-54. PubMed ID: 3425025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.